98%
921
2 minutes
20
Introduction: Obesity is a growing public health issue worldwide, and anxiety is a major psychological disorder associated with obesity. Electroacupuncture (EA) has been proven to be a feasible treatment modality for obesity and anxiety in clinical practice. However, data on the effectiveness of EA for anxiety patients with obesity are lacking. Therefore, this study aimed to evaluate the effectiveness and safety of EA for anxiety in patients with obesity and to observe the brain functional status of the patients and the intervention effects of EA on brain function by using functional MRI (fMRI).
Methods And Analysis: In this randomised, blinded, sham-controlled clinical trial, 72 patients with obesity from two hospitals with anxiety will be randomly divided into EA and control groups in a 1:1 ratio by using a random number table. Patients in the EA group will receive EA treatment with penetrating needling at specific acupoints for 8 weeks. The control group will receive Park's acupuncture with non-penetrating needling. Weight, waist, body mass index, Self-rating Anxiety Scale score, State-Trait Anxiety Inventory score and Pittsburgh Sleep Quality Index will be measured before treatment, after 8 weeks of treatment and at the 1-month follow-up evaluation. Objective metabolic parameters such as triglyceride, total cholesterol, fasting blood glucose, ghrelin, leptin, cortisol and adrenocorticotropic hormone levels will also be measured before and after the 8-week intervention. 20 patients will be randomly selected from the EA and control groups before treatment. These randomly selected patients will undergo fMRI scans before and after treatment. Regional homogeneity, amplitude of low-frequency fluctuation and resting-state functional connectivity will be evaluated to compare the dysfunctional brain regions between two groups of patients after treatment.
Ethics And Dissemination: The study protocol has been approved by the Hospital Ethics Committee of Second Affiliated Hospital of Anhui University of Chinese Medicine (2023-zj-42). Informed consent will be obtained prior to starting study-related procedures. The results will be disseminated in peer-reviewed journals and at scientific conferences.
Trial Registration Number: Chinese Clinical Trial Registry. ChiCTR2400083594, registered 29 April 2024.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12265808 | PMC |
http://dx.doi.org/10.1136/bmjopen-2024-093916 | DOI Listing |
Pol Merkur Lekarski
September 2025
VOLODYMYR DAHL EAST UKRAINIAN NATIONAL UNIVERSITY, KYIV, UKRAINE.
Objective: Aim: The aim is to conduct medical and sociological research on public awareness of the impact of rational nutrition on promoting human health and preventing chronic non-communicable diseases.
Patients And Methods: Materials and Methods: The research was conducted in 2022-2024 and involved 214 respondents of different ages and genders who were patients of outpatient clinics in Zhytomyr (Ukraine). Research methods included theoretical analysis of literary sources, medical and sociological (questionnaire), mathematical and statistical, system analysis, and logical generalization.
J Bras Pneumol
September 2025
. Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo (SP) Brasil.
Objective: To describe the sociodemographic and clinical characteristics of individuals exposed to smoking or biomass smoke and followed at primary health care (PHC) centers across three states in Brazil.
Methods: This was a cross-sectional multicenter study including patients followed at any of four PHC centers in Brazil. Patients ≥ 35 years of age who were smokers or former smokers, or were exposed to biomass smoke were included, the exception being those with physical/mental disabilities and those who were pregnant.
J Laparoendosc Adv Surg Tech A
September 2025
Department of Surgery, Veterans Affairs Medical Center, Washington, District of Columbia, USA.
The rising prevalence of obesity in the United States is paralleled by an increase in type II diabetes (T2D) and metabolic-associated steatotic liver disease. While lifestyle changes often do not afford sustainable weight loss, bariatric surgery, particularly sleeve gastrectomy (SG), offers a durable solution. This study investigates long-term outcomes in Veterans who underwent SG with concurrent liver biopsy.
View Article and Find Full Text PDFCurr Atheroscler Rep
September 2025
Division of Gastroenterology and Hepatology, Lynda K. and David M. Underwood Center for Digestive Health, Houston Methodist Hospital, Houston, TX, USA.
Purpose Of Review: This review aims to characterize the known cardiovascular (CV) manifestations associated with inflammatory bowel disease (IBD) and the underlying mechanisms driving these associations.
Recent Findings: Gut dysbiosis, a hallmark of patients with IBD, can result in both local and systemic inflammation, thereby potentially increasing the risk of cardiovascular disease (CVD) in the IBD population. Micronutrient deficiencies, anemia, and sarcopenia independently increase the risk of CVD and are frequent comorbidities of patients with IBD.